These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38418719)

  • 1. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Lindquist S; Frederiksen K; Petersen LK; Kjær SK
    Int J Cancer; 2024 Jul; 155(1):61-70. PubMed ID: 38418719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
    Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK
    Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
    Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
    Smith JS; Backes DM; Hoots BE; Kurman RJ; Pimenta JM
    Obstet Gynecol; 2009 Apr; 113(4):917-924. PubMed ID: 19305339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.
    Insinga RP; Liaw KL; Johnson LG; Madeleine MM
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1611-22. PubMed ID: 18628412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for invasive squamous cell carcinoma of the vulva and vagina--population-based case-control study in Denmark.
    Madsen BS; Jensen HL; van den Brule AJ; Wohlfahrt J; Frisch M
    Int J Cancer; 2008 Jun; 122(12):2827-34. PubMed ID: 18348142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
    Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.
    De Vuyst H; Clifford GM; Nascimento MC; Madeleine MM; Franceschi S
    Int J Cancer; 2009 Apr; 124(7):1626-36. PubMed ID: 19115209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
    Mpunga T; Chantal Umulisa M; Tenet V; Rugwizangoga B; Milner DA; Munyanshongore C; Heideman DAM; Bleeker MCG; Tommasino M; Franceschi S; Baussano I; Gheit T; Sayinzoga F; Clifford GM
    Int J Cancer; 2020 Mar; 146(6):1514-1522. PubMed ID: 31173641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
    Nygård M; Hansen BT; Dillner J; Munk C; Oddsson K; Tryggvadottir L; Hortlund M; Liaw KL; Dasbach EJ; Kjær SK
    PLoS One; 2014; 9(2):e88323. PubMed ID: 24505474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
    Gilbert DC; Wakeham K; Langley RE; Vale CL
    Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of human papillomavirus-related anogenital precancer and cancer in women with diabetes: A nationwide registry-based cohort study.
    Reinholdt K; Thomsen LT; Munk C; Dehlendorff C; Aalborg GL; Carstensen B; Jørgensen ME; Kjaer SK
    Int J Cancer; 2021 May; 148(9):2090-2101. PubMed ID: 33129233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
    Befano B; Wentzensen N; Lorey T; Poitras N; Cheung LC; Schiffman M; Clarke MA; Cohen C; Kinney W; Locke A; Castle PE
    Gynecol Oncol; 2024 May; 184():89-95. PubMed ID: 38301311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
    Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
    J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
    J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
    J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year relative survival for human papillomavirus-associated cancer sites.
    Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
    Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
    Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
    Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.